Abstract:Introduction: Gut microbiota has emerged as a pivotal player in cardiovascular health and disease, extending its influence beyond the gut through intricate metabolic processes and interactions with the immune system. Accumulating evidence supports a significant association between gut microbiota and cardiovascular diseases such as atherosclerosis, hypertension, and heart failure. Dietary patterns have been identified as key factors shaping the composition of the gut microbiota and exerting notable impacts on cardiovascular health. Probiotics and prebiotics have shown promise in mitigating the risks of cardiovascular disease by modulating key cardiovascular parameters. Faecal microbiota transplantation (FMT) has recently emerged as a novel and intriguing therapeutic strategy. Aim: This review paper aims to explore and elucidate the multifaceted role of gut microbiota in cardiovascular health. It will also address the prevailing challenges and limitations in gut microbiota studies, emphasizing the importance of future research in overcoming these obstacles to expand our understanding of the gut-heart axis. Materials and methods: A comprehensive literature search was conducted using various databases including ClinicalTrials, Google Scholar, PubMed, ScienceDirect, MEDLINE, and Ovid Resources. The search strategy included utilizing keywords such as "Gut microbiota," "Randomized controlled trials (RCTs)," "Gut-heart axis," "Dysbiosis," "Diet," "Probiotics," "Prebiotics," "Faecal Microbiota transplantation," "cardiovascular disease," "Meta-analyses," and other compatible terms thereof. Only articles written in English were considered, and selection criteria included relevance to the research objectives, reasonable sample sizes, and robust methodology. In addition to the identified articles, meta-analyses, animal models and studies, and references from the selected articles were also examined to ensure a comprehensive review of the literature. Results: Dietary patterns exert a significant influence on the composition of the gut microbiota, and certain diets, such as the Mediterranean diet, have been associated with a favourable gut microbiota profile and a reduced risk of cardiovascular disease (CVD). Probiotics and prebiotics have emerged as potential interventions to mitigate CVD risks by modulating blood pressure, glycemic control, lipid profiles, and gut dysbiosis. Another innovative therapeutic approach is FMT, which involves transferring faecal material from a healthy donor to restore a balanced gut microbiota. FMT holds promise for improving cardiometabolic parameters in individuals with CVD, although further research is needed to elucidate its precise mechanisms and assess its effectiveness. Conclusion: The gut microbiota is emerging as a potential therapeutic target for CVD prevention and management. However, current research has limitations, including the need for larger and more diverse studies, the challenges of establishing causality, and concerns regarding the long-term consequences and safety of gut microbiota modulation. Despite these limitations, understanding the gut-heart axis holds promise for the development of personalized therapies and interventions for cardiovascular health. Further research is needed to expand our knowledge and address the ethical and safety issues associated with gut microbiota modification.

Multi-omic links between gut microbiome and cardiovascular disease

Gut microbes may influence cardiovascular health

Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease

Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria

Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases

Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target

The Gut Microbiome in Atherosclerotic Cardiovascular Disease.

Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk

Relationship between gut microbiota and circulating metabolites in population-based cohorts

Unveiling the microbiota-metabolite-myocardium axis: a novel perspective on cardiovascular health

Multi-omics approaches for revealing the complexity of cardiovascular disease

The Interplay of Microbiome Dysbiosis and Cardiovascular Disease

Exploring the presence of oral bacteria in non-oral sites of patients with cardiovascular diseases using whole metagenomic data

Circulating microbiota and metabolites: Insights into cardiovascular diseases

Exploring the Gut Microbiota and Cardiovascular Disease

Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS study

Unlocking the gut-heart axis: exploring the role of gut microbiota in cardiovascular health and disease

Gut Microbes in Cardiovascular Diseases and Their Potential Therapeutic Applications

Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality

Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals

Role of gut microbiota in cardiovascular diseases - a comprehensive review